{"id":25199,"date":"2025-04-01T13:57:43","date_gmt":"2025-04-01T13:57:43","guid":{"rendered":"https:\/\/www.euforea.org\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/"},"modified":"2026-08-20T07:57:06","modified_gmt":"2026-08-20T07:57:06","slug":"remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/","title":{"rendered":"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"25199\" class=\"elementor elementor-25199 elementor-14712\" data-elementor-post-type=\"news\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0b3eb1b e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent\" data-id=\"0b3eb1b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d3cd1d5 elementor-widget elementor-widget-euforea_general_content\" data-id=\"d3cd1d5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_content.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n    <div data-quickedit-entity-id=\"paragraph\/842\" class=\"paragraph paragraph--text-columns paragraph-id--842 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\" data-once=\"quickedit\" data-quickedit-entity-instance-id=\"0\">\n      <div class=\"inner--wide\">\n        <div class=\"text__text text text--paragraph\">\n        \t          <p>Remissie is onlangs voorgesteld als het nieuwe behandeldoel bij CRSwNP of het neuspoliepsyndroom door de EUFOREA \/ European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA\/EPOS), evenals door wereldwijde leiders in de rhinologie. Bij CRSwNP wordt remissie gedefinieerd als een langdurige staat van controle, zonder hinderlijke symptomen gerapporteerd door de pati\u00ebnt gedurende ten minste 12 maanden, zonder de noodzaak van orale corticostero\u00efden of endoscopische sinuschirurgie (ESS), en zonder endoscopische tekenen van actieve ziekte. <\/p>\n<p>Dit nieuwe behandeldoel moet worden aangemoedigd door de NKO-gemeenschap en CRSwNP-pati\u00ebnten, aangezien aanhoudende symptomen die niet verlicht worden door historische benaderingen, kunnen worden verminderd door nieuwe therapie\u00ebn, waaronder biologicals. Het doel van de therapie voor CRSwNP is lang het bereiken van controle geweest, waarbij scores van de Visual Analogue Scale (VAS) en de Sino-Nasal Outcome Test (SNOT-22) artsen begeleiden naar een stapsgewijze behandeling gericht op controle. <\/p>\n<p><strong>Co-auteurs:<\/strong> Peter Hellings, Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior <\/p>\n        <\/div>\n      <\/div>\n    <\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7182727 elementor-widget elementor-widget-euforea_general_hover\" data-id=\"7182727\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"euforea_general_hover.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"paragraphs\">\n\t\t\t\t<div class=\"inner--wide\">\n\t\t\t<div class=\"text__text text text--paragraph\">\t\t\n\t\t\t\t<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=3267\" target=\"_blank\">\n\t\t\t\t\t<strong>Open Access in de rhinologie<\/strong><\/a><\/span>\n\t\t\t\t<\/p>\t\t\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Remissie is onlangs voorgesteld als het nieuwe behandeldoel bij CRSwNP of het neuspoliepsyndroom door de EUFOREA \/ European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA\/EPOS), evenals door wereldwijde leiders in de rhinologie. Bij CRSwNP wordt remissie gedefinieerd als een langdurige staat van controle, zonder hinderlijke symptomen gerapporteerd door de pati\u00ebnt gedurende ten minste 12 maanden, zonder de noodzaak van orale corticostero\u00efden of endoscopische sinuschirurgie (ESS), en zonder endoscopische tekenen van actieve ziekte. Dit nieuwe behandeldoel moet worden aangemoedigd door de NKO-gemeenschap en CRSwNP-pati\u00ebnten, aangezien aanhoudende symptomen die niet verlicht worden door historische benaderingen, kunnen worden verminderd door nieuwe therapie\u00ebn, waaronder biologicals. Het doel van de therapie voor CRSwNP is lang het bereiken van controle geweest, waarbij scores van de Visual Analogue Scale (VAS) en de Sino-Nasal Outcome Test (SNOT-22) artsen begeleiden naar een stapsgewijze behandeling gericht op controle. Co-auteurs: Peter Hellings, Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Open Access in de rhinologie<\/p>\n","protected":false},"author":9,"featured_media":25202,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[267],"tags":[],"class_list":["post-25199","news","type-news","status-publish","has-post-thumbnail","hentry","category-publicaties"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP) - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP)\" \/>\n<meta property=\"og:description\" content=\"Remissie is onlangs voorgesteld als het nieuwe behandeldoel bij CRSwNP of het neuspoliepsyndroom door de EUFOREA \/ European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA\/EPOS), evenals door wereldwijde leiders in de rhinologie. Bij CRSwNP wordt remissie gedefinieerd als een langdurige staat van controle, zonder hinderlijke symptomen gerapporteerd door de pati\u00ebnt gedurende ten minste 12 maanden, zonder de noodzaak van orale corticostero\u00efden of endoscopische sinuschirurgie (ESS), en zonder endoscopische tekenen van actieve ziekte. Dit nieuwe behandeldoel moet worden aangemoedigd door de NKO-gemeenschap en CRSwNP-pati\u00ebnten, aangezien aanhoudende symptomen die niet verlicht worden door historische benaderingen, kunnen worden verminderd door nieuwe therapie\u00ebn, waaronder biologicals. Het doel van de therapie voor CRSwNP is lang het bereiken van controle geweest, waarbij scores van de Visual Analogue Scale (VAS) en de Sino-Nasal Outcome Test (SNOT-22) artsen begeleiden naar een stapsgewijze behandeling gericht op controle. Co-auteurs: Peter Hellings, Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Open Access in de rhinologie\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T07:57:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1748\" \/>\n\t<meta property=\"og:image:height\" content=\"1015\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/\",\"name\":\"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP) - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"datePublished\":\"2025-04-01T13:57:43+00:00\",\"dateModified\":\"2026-08-20T07:57:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/news\\\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP) - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/","og_locale":"nl_NL","og_type":"article","og_title":"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP)","og_description":"Remissie is onlangs voorgesteld als het nieuwe behandeldoel bij CRSwNP of het neuspoliepsyndroom door de EUFOREA \/ European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA\/EPOS), evenals door wereldwijde leiders in de rhinologie. Bij CRSwNP wordt remissie gedefinieerd als een langdurige staat van controle, zonder hinderlijke symptomen gerapporteerd door de pati\u00ebnt gedurende ten minste 12 maanden, zonder de noodzaak van orale corticostero\u00efden of endoscopische sinuschirurgie (ESS), en zonder endoscopische tekenen van actieve ziekte. Dit nieuwe behandeldoel moet worden aangemoedigd door de NKO-gemeenschap en CRSwNP-pati\u00ebnten, aangezien aanhoudende symptomen die niet verlicht worden door historische benaderingen, kunnen worden verminderd door nieuwe therapie\u00ebn, waaronder biologicals. Het doel van de therapie voor CRSwNP is lang het bereiken van controle geweest, waarbij scores van de Visual Analogue Scale (VAS) en de Sino-Nasal Outcome Test (SNOT-22) artsen begeleiden naar een stapsgewijze behandeling gericht op controle. Co-auteurs: Peter Hellings, Eugenio De Corso, Vibeke Backer, Manuel Bernal-Sprekelsen, Yvonne Chan, Diego M. Conti, Marjolein Cornet, Wytske Fokkens, Philippe Gevaert, Joseph Han, Claire Hopkins, Basile Landis, Susanne Lau, Stella Lee, Valerie Lund, Joaquim Mullol, Anju Peters, Sven Schneider, Brent Senior Open Access in de rhinologie","og_url":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","article_modified_time":"2026-08-20T07:57:06+00:00","og_image":[{"width":1748,"height":1015,"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/","url":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/","name":"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP) - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","datePublished":"2025-04-01T13:57:43+00:00","dateModified":"2026-08-20T07:57:06+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/REMISSION-IN-CHRONIC-RHINOSINUSITIS-WITH-NASAL-POLYPS-CRSwNP-Paper-Teaser.jpg","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/nl\/news\/remissie-bij-chronische-rhinosinusitis-met-neuspoliepen-crswnp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Remissie bij chronische rhinosinusitis met neuspoliepen (CRSwNP)"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=25199"}],"version-history":[{"count":1,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25199\/revisions"}],"predecessor-version":[{"id":25203,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/25199\/revisions\/25203"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/25202"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=25199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=25199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=25199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}